SCRUITINIER''S REPORT AND REPORT UNDER REGULATION 44
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beryl Drugs Limited held its 32nd Annual General Meeting on 30 September 2025 in Indore, with voting conducted via remote e-voting and physical poll. Four resolutions were tabled: (1) adoption of audited financial statements for FY ending 31 March 2025, (2) re-appointment of Mr. Sudhir Sethi as Director retiring by rotation, (3) appointment of Mrs. Dipika Kataria as Secretarial Auditor for FY 2025-26 to FY 2029-30, and (4) re-appointment of Mr. Sanjay Sethi as Managing Director. All four resolutions were passed with 100% votes in favour and zero votes against. Total turnout was low, with only 31.88% of the 50.72 lakh outstanding shares being polled across just 50 shareholders (9 via e-voting and 41 by poll).
The resolutions were routine and approved unanimously, so no material governance shock is expected. Shareholders should note the 5-year appointment of the Secretarial Auditor and continuation of Mr. Sanjay Sethi as Managing Director, both of which consolidate existing management arrangements. A minor governance concern is that the AGM Scrutinizer (Dipika Kataria) is the same person being appointed as Secretarial Auditor.